Alexion Pharmaceuticals - Archives

2008 Archives

Soliris(R) Reduced Measures of Thrombosis and Inflammation, and Decreased Indicators of Pulmonary Hypertension, in Studies of Patients with PNH

Tuesday, December 9, 2008
Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH

Monday, December 8, 2008
First Clinical Experience With Soliris(R) in Treating Patients With Two Rare Complement-Mediated Diseases Presented at ASH Annual Meeting

Sunday, December 7, 2008
Alexion to Present at the 20th Annual Piper Jaffray Health Care Conference

Tuesday, November 25, 2008
David W. Keiser to Retire as President of Alexion

Tuesday, November 11, 2008
Researchers to Present Additional Data on Soliris(R) (eculizumab) for the Treatment of PNH at the ASH Annual Meeting

Monday, November 10, 2008
Alexion to Present at Investor Conferences

Tuesday, November 4, 2008
Alexion Reports Third Quarter 2008 Results

Thursday, October 23, 2008
Alexion Pharmaceuticals Invites You to Participate in its Third Quarter 2008 Results Conference Call and Web Cast

Wednesday, October 8, 2008
^® Receives 2008 Prix Galien USA Award for Best Biotechnology Product"> Alexion's Soliris^® Receives 2008 Prix Galien USA Award for Best Biotechnology Product

Thursday, September 25, 2008
Alexion to Present at the UBS Global Life Sciences Conference

Tuesday, September 16, 2008
Alexion to Present at the Morgan Stanley Global Healthcare Unplugged Conference

Tuesday, September 2, 2008
Alexion Secures U.S. Patent for ALXN6000, a First-In-Class Anti-CD200 Monoclonal Antibody

Thursday, August 7, 2008
Alexion Reports Second Quarter 2008 Results

Tuesday, July 29, 2008
Alexion Pharmaceuticals Invites You to Participate in its Second Quarter 2008 Results Conference Call and Web Cast

Thursday, July 10, 2008
Alexion to Present at the Jefferies & Co. 2nd Annual Healthcare Conference

Wednesday, June 18, 2008
Soliris(R) Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis

Sunday, June 15, 2008
Alexion to Present at the William Blair 28th Annual Growth Stock Conference

Friday, June 13, 2008
Alexion to Present at the Goldman Sachs 29th Annual Global Healthcare Conference

Thursday, June 5, 2008
Alexion to Present at Citi's 2008 Healthcare Conference

Wednesday, May 14, 2008
Notice of Time Change for Alexion's Presentation at the Bank of America 2008 Health Care Conference

Friday, May 9, 2008
Alexion to Present at the Bank of America 2008 Health Care Conference

Tuesday, May 6, 2008
Alexion Reports First Quarter 2008 Results

Wednesday, April 30, 2008
Alexion to Present at the Morgan Stanley Global Healthcare Unplugged Conference

Thursday, April 24, 2008
Alexion Pharmaceuticals Invites You to Participate in its First Quarter 2008 Results Conference Call and Web Cast

Monday, April 14, 2008
Alexion Completes Enrollment in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan

Thursday, March 20, 2008
Alexion to Present at Investor Conferences

Tuesday, March 11, 2008
Alexion Acquires All Rights to OMRF Patents Related to Soliris(R)

Thursday, February 14, 2008
Alexion Reports Fourth Quarter and Full Year 2007 Results

Thursday, February 14, 2008
Alexion Pharmaceuticals Invites You to Participate in its Fourth Quarter and Full Year 2007 Results Conference Call and Web Cast

Monday, January 28, 2008
Alexion to Present at the Wachovia Securities 2008 Healthcare Conference

Thursday, January 24, 2008
Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan

Monday, January 7, 2008
Alexion to Present at the 26th Annual JP Morgan Healthcare Conference

Wednesday, January 2, 2008